CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42 enrolled
Drug / intervention
Granulocyte/Polymorphonuclear Cell Collection (COBE Spectra System) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01805180
NCT01805180N/ACompleted
CompareCT.gov

A Controlled Evaluation of the Spectra Optia® Apheresis System's Granulocyte / Polymorphonuclear (PMN) Cell Collection Procedure

Terumo BCT·interventional·Posted Mar 6, 2013·Updated Mar 18, 2015

In Brief

A clinical study evaluating Granulocyte/Polymorphonuclear Cell Collection (COBE Spectra System) and Granulocyte/Polymorphonuclear Cell Collection (Spectra Optia System) for Granulocyte/ Polymorphonuclear Cells. Completed, enrolled 42 participants across 3 sites.

Detailed Summary

The purpose of this study is to compare the procedures for the collection PMN cells on Terumo BCT's Spectra Optia® and COBE® Spectra Apheresis Systems.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGranulocyte/ Polymorphonuclear Cells
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 6, 2013
Enrollment StartFeb 1, 2013
Primary CompletionJul 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 13.3 years ago

Interventions

Granulocyte/Polymorphonuclear Cell Collection (COBE Spectra System)device

In Arm 1 the first PMN cell collection will be performed using the Spectra Optia System and the second PMN cell collection using the COBE Spectra System.

Granulocyte/Polymorphonuclear Cell Collection (Spectra Optia System)device

In Arm 2 the first PMN cell collection will be performed using the COBE Spectra System and the second PMN cell collection using the Spectra Optia System.